Supplemental material
Journal of Medical Economics
Volume 24, 2021 - Issue 1
Open access
3,447
Views
4
CrossRef citations to date
0
Altmetric
Oncology
Cost-effectiveness of nivolumab in squamous and non-squamous non-small cell lung cancer in Canada and Sweden: an update with 5-year data
Mohammad A. Chaudharya Worldwide Health Economics and Outcomes Research, Bristol Myers Squibb, Princeton, NJ, USACorrespondence[email protected]
, Christoffer Holmbergb Value & Health Economics and Outcomes Research, Bristol Myers Squibb, Solna, Sweden
, Khalid Lakhdaric Market Access & HTA, Bristol Myers Squibb Canada, St. Laurent, QC, Canada
, Caitlin Smared Parexel International, London, UK
, Chloi Therioud Parexel International, London, UK
, Peter Daled Parexel International, London, UK
& John R. Penroda Worldwide Health Economics and Outcomes Research, Bristol Myers Squibb, Princeton, NJ, USA
show all
Pages 607-619
|
Received 17 Dec 2020, Accepted 08 Apr 2021, Published online: 06 May 2021
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.